FOLH1 and neoplasm: However, the PSMA+ PC3 PIP and PSMA− PC3 flu cells have the advantage of being isogenic and androgen-independent cell lines and are anticipated to display similar biological factors for evaluating tumor pharmacokinetics, except for the PSMA expression levels.